Tag: acute pulmonary embolism

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (12)

Among the excluded patients, the most common situation was a “low probability of PE” V/Q scan interpretation and low clinical suspicion for PE. Another shortcoming of this study is a limited experience in applying the FPA assay designed for plasma to urine testing. One investigation suggests that urine contains significant amount of carboxyterminally degraded FPA, which may be undetected by assays that contain antibody directed mostly against the carboxyterminal. This reduced sensitivity may cause spuriously…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (11)

Conversely, an obstructed or severely reduced blood flow to a pulmonary segment can be caused by focal parenchymal disease or an embolism other than a venous thrombosis. In these instances, the uFPA would be normal; however, V/Q scans may be suggestive of PE. Indeed, there is one patient in this study who had a “high probability of PE” V/Q scan interpretation and normal uFPA concentration (Fig 1). A PA study done within a few hours…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (10)

Therefore, it is generally agreed that although elevated levels of pFPA or uFPA are not specific for PE, the normal test indicates that the likelihood of PE is very low. ampicillin antibiotic Although pFPA levels can be useful in excluding PE in suspected patients, the clinical utility of the test has been hampered by the following factors: (1) a blood sample must be carefully obtained by experienced personnel using an atraumatic technique; and (2) the…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (9)

All the patients in that study were examined within the first 24 h after the onset of symptoms. In another study, only two of 18 patients with PE had a normal pFPA level; however, both patients were examined more than five days after the onset of symptoms. These findings suggest that FPA generation may normalize in patients examined more than 24 h after the onset of symptoms. Furthermore, the inverse relationship of symptom duration (time…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (8)

Discussion Currently, V/Q scan is the mainstay in evaluation of patients with suspected PE and frequently is the initial diagnostic procedure that has a major impact on patient treatment. A normal perfusion lung scan virtually excludes PE. On the other hand, the “high probability of PE” V/Q scan in patients with a compatible clinical presentation is accepted widely as sufficient evidence of PE. However, a significant number of patients have equivocal V/Q scan findings and…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (7)

The times between the onset of symptoms and uFPA testing were significantly (p = 0.025) shorter in patients with PE (13 h, range 6 to 24 h) than those without PE (27.6 h, range 8 to 72 h). PE was diagnosed by PA in four patients and by the V/Q scan criteria in three patients. PE was excluded by a normal V/Q scan in 16 patients and by negative PA in six patients. Individual patients…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (6)

Statistical Analyses As noted previously by others, the frequency distribution of FPA is log-normal. Therefore, logarithmic transformation was performed to obtain a normal, ie, gaussian, frequency distribution. The differences between the groups were then tested by the modified t test and a p value of less than 0.05 was considered significant. Thus, the uFPA data are in the form of their geometric means ± the geometric standard deviation (SD). Other data are expressed as the…

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (5)

The urine samples were collected and 3-ml aliquots were transferred to special tubes containing 0.75 ml of an aqueous anticoagulant solution. The anticoagulant solution contained the following (all values are final concentrations): sodium azide, 0.2 mg/ml; sodium citrate, 22 mmol; porcine interstitial heparin (Sigma H7005), 200 U/ml; and aprotonin (Sigma A-1153), 0.2 trypsin inhibitory units (TIU)/ml. All the samples were frozen within 20 min of collection at — 70°C. buy cheap antibiotics

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (4)

“Moderate probability of PE”: (1) Normal chest roentgenogram, normal ventilation study, and several subsegmental perfusion defects the sum of which is equivalent to two segments. (2) Severe chronic obstructive airways disease, no opacification on the chest roentgenogram, and matched or partially unmatched perfusion defects. (3) Opacification of the chest roentgenogram and nonsegmental perfusion defect that is approximately equal in size to the area of the roentgenogram opacification. proventil inhaler

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (3)

Patients Excluded from Analysis Patients with conditions known to alter FPA levels (those who had undergone surgery within four days and those receiving anticoagulation therapy) were excluded from the final analyses. Patients who had an abnormal perfusion scan but did not undergo PA were excluded, except for those who fulfilled diagnostic criterion 2. buy birth control online V/Q Lung Scan and Pulmonary Angiography A detailed description of the technique and interpretation of V/Q lung scan…